BEAM
Price
$16.77
Change
-$0.22 (-1.29%)
Updated
Jun 20 closing price
Capitalization
1.69B
50 days until earnings call
XNCR
Price
$8.54
Change
+$0.18 (+2.15%)
Updated
Jun 20 closing price
Capitalization
607.8M
37 days until earnings call
Interact to see
Advertisement

BEAM vs XNCR

Header iconBEAM vs XNCR Comparison
Open Charts BEAM vs XNCRBanner chart's image
Beam Therapeutics
Price$16.77
Change-$0.22 (-1.29%)
Volume$2.19M
Capitalization1.69B
Xencor
Price$8.54
Change+$0.18 (+2.15%)
Volume$1.65M
Capitalization607.8M
BEAM vs XNCR Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. XNCR commentary
Jun 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2025
Stock price -- (BEAM: $16.76 vs. XNCR: $8.54)
Brand notoriety: BEAM and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 118% vs. XNCR: 177%
Market capitalization -- BEAM: $1.69B vs. XNCR: $607.8M
BEAM [@Biotechnology] is valued at $1.69B. XNCR’s [@Biotechnology] market capitalization is $607.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 6 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -1.76% price change this week, while XNCR (@Biotechnology) price change was -7.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than XNCR($608M). BEAM YTD gains are higher at: -32.419 vs. XNCR (-62.837). XNCR has higher annual earnings (EBITDA): -161.68M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. XNCR (470M). XNCR has less debt than BEAM: XNCR (67.8M) vs BEAM (158M). XNCR has higher revenues than BEAM: XNCR (127M) vs BEAM (63.6M).
BEAMXNCRBEAM / XNCR
Capitalization1.69B608M277%
EBITDA-399.03M-161.68M247%
Gain YTD-32.419-62.83752%
P/E RatioN/AN/A-
Revenue63.6M127M50%
Total Cash1.22B470M260%
Total Debt158M67.8M233%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMXNCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEECX11.010.01
+0.09%
TETON Westwood Equity A
JDEUX43.94-0.10
-0.23%
JPMorgan US Research Enhanced Equity R6
SGAPX23.65-0.11
-0.46%
Virtus SGA Global Growth I
TINVX23.99-0.17
-0.70%
Thornburg International Growth R4
INDCX12.46-0.11
-0.88%
Victory Pioneer Disciplined Growth C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.35%
CRSP - BEAM
72%
Closely correlated
-0.41%
NTLA - BEAM
64%
Loosely correlated
-4.17%
RXRX - BEAM
63%
Loosely correlated
-1.76%
ABSI - BEAM
57%
Loosely correlated
+1.45%
AXON - BEAM
57%
Loosely correlated
+0.85%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+2.15%
CRNX - XNCR
59%
Loosely correlated
N/A
BEAM - XNCR
57%
Loosely correlated
-1.35%
KRYS - XNCR
55%
Loosely correlated
+0.28%
BCYC - XNCR
54%
Loosely correlated
N/A
SYRE - XNCR
54%
Loosely correlated
-0.46%
More